This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Finance & Accounting for Bioscience Companies
September 18-19, 2024
Omni Boston Hotel at the SeaportBoston, MA

Rafal Kowalczyk
VP, Head of Finance and Treasurer at Sail Biomedicines


Rafal Kowalczyk is Vice President, Head of Finance for Sail Biomedicines, a Flagship Pioneering Company. He held the same role at Senda Biosciences pre-merger of two Flagship Portfolio Companies, and bringing almost two decades of experience across multiple private and public biotech startups, the pharmaceutical industry and the defense industry.

Rafal is responsible for Financial Planning and Analysis, Accounting and Financial Operations, playing a key role in the financial and strategic steering of the organization.

Rafal has served in senior financial roles at Passage Bio, Spark Therapeutics (acquired by Roche), as well as AstraZeneca. Before his career in industry, Rafal led Finance roles at United Technologies (now Raytheon Technologies). Rafal holds an M.B.A. in Finance & Entrepreneuri­alism from Northeastern University and a B.S. in Finance from Quinnipiac University.

Agenda Sessions

  • Collaborations and Mergers from the Accounting and Finance Perspectives